Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
Platinum drugs are among the most effective anticancer agents, but their mode of action is still not fully understood. We therefore carried out a systematic investigation on the cellular activities of cisplatin, carboplatin and oxaliplatin in A498 kidney cancer cells. Cytotoxicity was higher for cis...
Main Authors: | Sarah Schoch, Sabine Gajewski, Jana Rothfuß, Andrea Hartwig, Beate Köberle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/18/6928 |
Similar Items
-
In Vitro Nephrotoxicity Studies of Established and Experimental Platinum-Based Compounds
by: Sarah Schoch, et al.
Published: (2021-08-01) -
Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy
by: Nesrine Benkafadar, et al.
Published: (2017-01-01) -
Breathing New Life into the Mechanisms of Platinum Resistance in Lung Adenocarcinoma
by: Alvaro Gonzalez-Rajal, et al.
Published: (2020-05-01) -
Platinum Complexes in Colorectal Cancer and Other Solid Tumors
by: Beate Köberle, et al.
Published: (2021-04-01) -
In vitro and in vivo evaluation of electrochemotherapy with trans-platinum analogue trans-[PtCl2(3-Hmpy)2]
by: Kranjc Simona, et al.
Published: (2017-09-01)